The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 601–700 of 1,072
Making Science Meaningful for Broad Audiences through Stories
ElShafie, S. J. (2018) · Integrative and Comparative Biology · doi:10.1093/icb/icy103 · Cited by 132
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges
Kalter, N., Fuster‐García, C., Silva, A., Ronco-Díaz, V., Roncelli, S., Turchiano, G., Gorodkin, J., Cathomen, T., Benabdellah, K., Lee, C. M., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102636 · Cited by 135
CRISPR/Cas9-mediated genome engineering of CHO cell factories: application and perspectives
Lee, J. S., Grav, L. M., Lewis, N. E., & Faustrup Kildegaard, H. (2015) · Biotechnology Journal · doi:10.1002/biot.201500082 · Cited by 117
DNA-binding-domain fusions enhance the targeting range and precision of Cas9
Bolukbasi, M. F., Gupta, A., Oikemus, S., Derr, A. G., Garber, M., Brodsky, M. H., Zhu, L. J., & Wolfe, S. A. (2015) · Nature Methods · doi:10.1038/nmeth.3624 · Cited by 115
“1): (1) compatibility of the protospacer-adjacent motif (PAM) element with the specificity of the PAM-interacting domain, and (2) complementarity of the guide RNA sequence to the target site.”
BackgroundChen, K., Xiao, H., Zeng, J., Gan, Y., Zhou, H., Huang, C., Yao, W., Xiao, W., Hu, J., Guan, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2020 · Cited by 121
Metabolic Engineering of Microorganisms for the Production of Natural Compounds
Park, S. Y., Yang, D., Ha, S. H., & Lee, S. Y. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700190 · Cited by 117
Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
Li, Y., Glass, Z., Huang, M., Chen, Z., & Xu, Q. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119711 · Cited by 130
Precision cancer mouse models through genome editing with CRISPR-Cas9
Mou, H., Kennedy, Z., Anderson, D. G., Yin, H., & Xue, W. (2015) · Genome Medicine · doi:10.1186/s13073-015-0178-7 · Cited by 113
Timin, A. S., Muslimov, A. R., Lepik, K. V., Epifanovskaya, O. S., Shakirova, A. I., Mock, U., Riecken, K., Okilova, M. V., Sergeev, V. S., Afanasyev, B. V., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.001 · Cited by 122
Accelerating Breeding for Heat Tolerance in Tomato (Solanum lycopersicum L.): An Integrated Approach
Ayenan, M. A. T., Danquah, A., Hanson, P. M., Ampomah‐Dwamena, C., Sodedji, K. A. F., Asante, I. K., & Danquah, E. Y. (2019) · Agronomy · doi:10.3390/agronomy9110720 · Cited by 128
“The three major technologies used for genome editing include zinc finger nuclease (ZFN) [128], transcription activator-like effector nucleases (TALENs), [129] and clustered regularly interspaced short palindromic repeat (CRISPR/cas9) [130,131].”
BackgroundAdvances in promoter engineering: Novel applications and predefined transcriptional control
Cazier, A. P., & Blazeck, J. (2021) · Biotechnology Journal · doi:10.1002/biot.202100239 · Cited by 122
Onsite detection of plant viruses using isothermal amplification assays
Bhat, A. I., Aman, R. A., & Mahfouz, M. M. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13871 · Cited by 122
“CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated) is a naturally occurring adaptive immune system used by prokaryotes such as bacteria and archaea to avoid invading viruses and plasmids (Doudna and Charpentier, 2014; Jinek et al., 2012).”
BackgroundCellular and Molecular Mechanisms of Palatogenesis
Lan, Y., Xu, J., & Jiang, R. (2015) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2015.07.002 · Cited by 131
“…genetics and developmental biology research and enabled unprecedented access to investigating the detailed functions of proteins, genes, RNAs, and other elements as well as cellular and molecular processes in the endogenous context (Doudna and Charpentier, 2014; Harrison et al., 2014).”
BackgroundXie, Y., Wang, D., Lan, F., Wei, G., Ni, T., Chai, R., Liu, D., Hu, S., Li, M., Li, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02456-y · Cited by 122
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
Naldini, L. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809958 · Cited by 110
“…exploit dimeric or monomeric protein-based DNA sequence recognition to tether an endonuclease on the target DNA, while the more recently developed CRISPR/Cas systems exploit RNA-based sequence recognition coupled to activation of the protein endonucleolytic activity (Doudna & Charpentier, 2014).”
BackgroundNaduthodi, M. I. S., Mohanraju, P., Südfeld, C., D’Adamo, S., Barbosa, M. J., & van der Oost, J. (2019) · Biotechnology for Biofuels · doi:10.1186/s13068-019-1401-3 · Cited by 112
CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation
Sun, W., Wang, J., Hu, Q., Zhou, X., Khademhosseini, A., & Gu, Z. (2020) · Science Advances · doi:10.1126/sciadv.aba2983 · Cited by 113
“(1) Untreated, (2) NC-27, (3) NC-17, (4) NC-12, (5) NC-6, (6) NC-0, (7) NC-free, (L) DNA ladder.”
Schenke, D., & Cai, D. (2020) · iScience · doi:10.1016/j.isci.2020.101478 · Cited by 118
Huggins, M. A., Sjaastad, F. V., Pierson, M., Kucaba, T. A., Swanson, W., Staley, C., Weingarden, A. R., Jensen, I. J., Danahy, D. B., Badovinac, V. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.028 · Cited by 114
“The availability of an extensive array of transgenic and knockout mouse strains, as well as the ease of manipulating the genome to generate novel strains as needed, has made the mouse increasingly valuable for studying functions of the immune system (Doudna and Charpentier, 2014).”
BackgroundTools for efficient genome editing; ZFN, TALEN, and CRISPR
Shamshirgaran, Y., Liu, J., Sumer, H., Verma, P. J., & Taheri-Ghahfarokhi, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2301-5_2 · Cited by 114
Box, A. M., McGuffie, M. J., O’Hara, B. J., & Seed, K. D. (2015) · Journal of Bacteriology · doi:10.1128/jb.00747-15 · Cited by 114
An overview of rapamycin: from discovery to future perspectives
Yoo, Y. J., Kim, H., Park, S. R., & Yoon, Y. J. (2017) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-016-1834-7 · Cited by 124
“The recent progress in genome engineering [29], systems biology [62], synthetic biology [74], and metabolic engineering [136] associated with the field of natural product research will enable scientists to enhance the production of rapamycin and generate more diverse rapalogs.”
BackgroundEngineering of temperature- and light-switchable Cas9 variants
Richter, F. M., Fonfara, I., Bouazza‐Arostegui, B., Schumacher, C. H., Bratovič, M., Charpentier, E., & Möglich, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkw930 · Cited by 123
“To test these concepts, we selected the RNA-guided sequence-specific DNA endonuclease Cas9 from Streptococcus pyogenes (9) as the target effector because of its eminent biological relevance (10) and the availability of powerful screening assays.”
MethodSelf-citationSheep and Goat Genome Engineering: From Random Transgenesis to the CRISPR Era
Kalds, P., Zhou, S., Cai, B., Liu, J., Wang, Y., Petersen, B., Sonstegard, T. S., Wang, X., & Chen, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00750 · Cited by 156
“Based on many years of research, CRISPR systems were developed from prokaryotic adaptive defense systems to robust gene-editing tools applicable throughout the entire biological kingdom (Doudna and Charpentier, 2014).”
BackgroundPrinciples of Genetic Engineering
Lanigan, T. M., Kopera, H. C., & Saunders, T. L. (2020) · Genes · doi:10.3390/genes11030291 · Cited by 133
“Prior to the adaptation of Streptococcus pyogenes Cas9 protein to cause chromosome breaks, three other endonuclease systems were used: (1) rare-cutting meganucleases, (2) zinc finger nucleases (ZFNs), and (3) transcription activator-like effector (TALE) nucleases (TALENs) [27].”
MethodThe Bacterial Origins of the CRISPR Genome-Editing Revolution
Sontheimer, E. J., & Barrangou, R. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.091 · Cited by 131
“19,20 21–25 The ensuing two-and-a-half years have seen a virtual explosion of technical development and end-user adoption, 3,4 to the point that the CRISPR revolution is now being described as the most significant technological advance in the life sciences since the advent of the polymerase chain…”
InfluentialNon-viral delivery of genome-editing nucleases for gene therapy
Wang, M., Glass, Z., & Xu, Q. (2016) · Gene Therapy · doi:10.1038/gt.2016.72 · Cited by 120
CRISPR/Cas approach: A new way of looking at plant-abiotic interactions
Mushtaq, M., Bhat, J. A., Mir, Z. A., Sakina, A., Ali, S., Singh, A. K., Tyagi, A., Salgotra, R. K., Dar, A. A., & Bhat, R. (2018) · Journal of Plant Physiology · doi:10.1016/j.jplph.2018.04.001 · Cited by 120
Efficient CRISPR–Cas9 mediated multiplex genome editing in yeasts
Wang, L., Deng, A., Zhang, Y., Liu, S., Liang, Y., Bai, H., Cui, D., Qiu, Q., Shang, X., Yang, Z., et al. (2018) · Biotechnology for Biofuels · doi:10.1186/s13068-018-1271-0 · Cited by 119
Prediction of CRISPR sgRNA Activity Using a Deep Convolutional Neural Network
Xue, L., Tang, B., Chen, W., & Luo, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00368 · Cited by 120
Harnessing Genome Editing Techniques to Engineer Disease Resistance in Plants
Mushtaq, M., Sakina, A., Wani, S. H., Shikari, A. B., Tripathi, P., Zaid, A., Galla, A., Abdelrahman, M., Sharma, M., Singh, A. K., et al. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00550 · Cited by 104
“CRISPR/Cas9 requires a duplex-RNA structure [CRISPR RNA (crRNA): transactivating crRNA (tracrRNA)] that guides Cas9 nucleases to the target DNA (Doudna and Charpentier, 2014; Khandagale and Nadaf, 2016; Ruiz de Galarreta and Lujambio, 2017).”
BackgroundBacterial exopolysaccharides: Chemical structures, gene clusters and genetic engineering
Sun, X., & Zhang, J. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.139 · Cited by 119
DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes
Plagens, A., Richter, H., Charpentier, E., & Randau, L. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv019 · Cited by 109
“pyogenes system has rapidly andwidely been recognized as an effective technology to target, edit or modify the genomes of a large variety of cells and organisms (Doudna and Charpentier 2014; Hsu, Lander and Zhang 2014).”
BackgroundMethodSelf-citationCRISPR-mediated Activation of Latent HIV-1 Expression
Limsirichai, P., Gaj, T., & Schaffer, D. V. (2016) · Molecular Therapy · doi:10.1038/mt.2015.213 · Cited by 108
Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery
Bolukbasi, M. F., Gupta, A., & Wolfe, S. A. (2015) · Nature Methods · doi:10.1038/nmeth.3684 · Cited by 123
dCas9: A Versatile Tool for Epigenome Editing
Brocken, D. J. W., Tark-Dame, M., & Dame, R. T. (2018) · Current Issues in Molecular Biology · doi:10.21775/cimb.026.015 · Cited by 105
Photo-controllable biochemistry: Exploiting the photocages in phototherapeutic window
Xiong, H., Xu, Y., Kim, B., Rha, H., Zhang, B., Li, M., Yang, G., & Kim, J. S. (2022) · Chem · doi:10.1016/j.chempr.2022.11.007 · Cited by 113
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
LaFountaine, J. S., Fathe, K., & Smyth, H. D. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.029 · Cited by 111
Zebrafish: A New Companion for Translational Research in Oncology
Barriuso, J., Nagaraju, R. T., & Hurlstone, A. F. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2921 · Cited by 115
“CRISPR/cas9 technology has advantages against TALEN technology in terms of the cloning required to prepare the plasmid for mRNA synthesis, the ability of targeting several loci at the same time and generating a phenotype already in the first generation of injected animals (32).”
BackgroundAdvancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
You, L., Tong, R., Li, M., Liu, Y., Xue, J., & Lü, Y. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.02.008 · Cited by 128
Applications of CRISPR/Cas9 in the Synthesis of Secondary Metabolites in Filamentous Fungi
Jiang, C., Lv, G., Tu, Y., Cheng, X., Duan, Y., Zeng, B., & He, B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638096 · Cited by 124
“This strategy, commonly termed CRISPR inhibition (CRISPRi), decreases the transcription of target DNA loci mainly by blocking transcriptional elongation, impeding transcription factor binding, or interfering with RNA polymerase transcription initiation (Bikard et al., 2013; Larson et al., 2013; Doudna and Charpentier,…”
BackgroundMethodInfluentialKurtz, S. E., Eide, C. A., Kaempf, A., Khanna, V., Savage, S. L., Rofelty, A., English, I., Ho, H., Pandya, R., Bolosky, W. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703094114 · Cited by 110
“Recent approaches that make use of single-cell imaging or flow cytometry (47–51), or CRISPR/ Cas9 gene silencing (52), will be useful in enhancing our initial view of combination efficacy and in identifying new targets.”
BackgroundLi, J., Zhang, Y., Zhang, Y., Yu, P., Pan, H., & Rollins, J. A. (2018) · mBio · doi:10.1128/mbio.00567-18 · Cited by 114
“The application of CRISPR-Cas systems to efficiently edit genomes has changed the course and speed of gene manipulation in diverse eukaryotic organisms (12).”
Benefits of genome-edited crops: expert opinion
Lassoued, R., Macall, D. M., Hesseln, H., Phillips, P. W. B., & Smyth, S. J. (2019) · Transgenic Research · doi:10.1007/s11248-019-00118-5 · Cited by 132
Marine Natural Products from Microalgae: An -Omics Overview
Lauritano, C., Ferrante, M. I., & Rogato, A. (2019) · Marine Drugs · doi:10.3390/md17050269 · Cited by 106
“org/article-detail?newsUrlName=doubling-down-on-developing-genetictools-for-marine-microbial-ecology) and the development of the CRISPR/Cas9 system [104], are bringing about major changes in the field, and are expected to greatly enhance our ability to engineer genomes of species deemed promising for natural products…”
BackgroundRationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity
Tan, Y., Chu, A. H. Y., Bao, S., Hoang, D. A., Kebede, F. T., Xiong, W., Ji, M., Shi, J., & Zheng, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906843116 · Cited by 119
Gao, Z., Fan, M.-H., Das, A. T., Herrera-Carrillo, E., & Berkhout, B. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa226 · Cited by 120
Wang, Y., Shahi, P. K., Xie, R., Zhang, H., Abdeen, A. A., Yodsanit, N., Ma, Z., Saha, K., Pattnaik, B. R., & Gong, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.052 · Cited by 107
“After the double-stranded DNA break is generated, gene deletion can be achieved by the nonhomologous end-joining (NHEJ) DNA repair pathway[30, 31].”
BackgroundYue, H., Huang, M., Tian, T., Xiong, E., & Zhou, X. (2021) · ACS Nano · doi:10.1021/acsnano.1c02372 · Cited by 111
G-triplex: A new type of CRISPR-Cas12a reporter enabling highly sensitive nucleic acid detection
Li, T., Hu, R., Xia, J., Xu, Z., Chen, D., Xi, J., Liu, B., Zhu, J., Li, Y., Yang, Y., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113292 · Cited by 110
The emerging role of nanotechnology in plant genetic engineering
Squire, H. J., Tomatz, S., Voke, E., Grandío, E. G., & Landry, M. P. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00037-5 · Cited by 118
Engineering yeast for the production of plant terpenoids using synthetic biology approaches
Bureau, J.-A., Oliva, M. E., Dong, Y., & Ignea, C. (2023) · Natural Product Reports · doi:10.1039/d3np00005b · Cited by 113
A Neural Basis for Control of Cichlid Female Reproductive Behavior by Prostaglandin F 2α
Juntti, S. A., Hilliard, A. T., Kent, K. R., Kumar, A. M., Nguyen, A., Jimenez, M. A., Loveland, J. L., Mourrain, P., & Fernald, R. D. (2016) · Current Biology · doi:10.1016/j.cub.2016.01.067 · Cited by 111
A coral-on-a-chip microfluidic platform enabling live-imaging microscopy of reef-building corals
Shapiro, O. H., Kramarsky‐Winter, E., Gavish, A. R., Stocker, R., & Vardi, A. (2016) · Nature Communications · doi:10.1038/ncomms10860 · Cited by 118
Liu, Q., Liu, W., Zeng, B., Wang, G., Hao, D., & Huang, Y. (2017) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2017.05.007 · Cited by 109
Synthetic biology advances and applications in the biotechnology industry: a perspective
Katz, L., Chen, Y. Y., González, R., Peterson, T. C., Zhao, H., & Baltz, R. H. (2018) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-018-2056-y · Cited by 120
Lin, W.-R., Tan, S.-I., Hsiang, C.-C., Sung, P.-K., & Ng, I.-S. (2019) · Bioresource Technology · doi:10.1016/j.biortech.2019.121932 · Cited by 108
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
Ivanov, I. E., Wright, A. V., Cofsky, J. C., Aris, K., Doudna, J. A., & Bryant, Z. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913445117 · Cited by 109
Self-citationParums, D. V. (2024) · Medical Science Monitor · doi:10.12659/msm.944204 · Cited by 109
Biological reality and parsimony in crop models—why we need both in crop improvement!
Hammer, G., Messina, C., Wu, A., & Cooper, M. (2019) · in silico Plants · doi:10.1093/insilicoplants/diz010 · Cited by 108
Resurrecting biodiversity: Advanced assisted reproductive technologies and biobanking
Bolton, R. L., Mooney, A., Pettit, M. T., Bolton, A. E., Morgan, L., Drake, G. J., Appeltant, R., Walker, S. L., Gillis, J. D., & Hvilsom, C. (2022) · Reproduction and Fertility · doi:10.1530/raf-22-0005 · Cited by 108
Role of developmental factors in hypothalamic function
Biran, J., Tahor, M., Wircer, E., & Levkowitz, G. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00047 · Cited by 115
“…such as the transcription activator-like effector nuclease (TALEN) or the clustered regularly interspaced short palindromic repeats (CRISPR) genome editing methods now allow efficient genetic manipulation and analysis of new candidate genes (Doudna and Charpentier, 2014; Wright et al., 2014).”
BackgroundResources for the design of CRISPR gene editing experiments
Graham, D. B., & Root, D. E. (2015) · Genome Biology · doi:10.1186/s13059-015-0823-x · Cited by 103
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
Sardone, V., Zhou, H., Muntoni, F., Ferlini, A., & Falzarano, M. S. (2017) · Molecules · doi:10.3390/molecules22040563 · Cited by 118
“In addition, the revolutionary CRISP-Cas9 genome editing may offer more novel therapeutic opportunities [150], if safety issues and off-target effects are solved.”
BackgroundDecoding non-random mutational signatures at Cas9 targeted sites
Taheri-Ghahfarokhi, A., Taylor, B. J. M., Nitsch, R., Lundin, A., Cavallo, A.-L., Madeyski-Bengtson, K., Karlsson, F., Clausen, M., Hicks, R., Mayr, L. M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky653 · Cited by 103
de Graeff, N., Jongsma, K. R., Johnston, J., Hartley, S., & Bredenoord, A. L. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0106 · Cited by 121
“(d) Disjunction between the expert and public debate Academic experts have made significant calls for public engagement with and debate about genome editing [4,28,70,126,152,153], particularly with regard to the possible use of gene drives [5,6,20,32,83,88,109,140].”
CRISPR-Cas9 directed genome engineering for enhancing salt stress tolerance in rice
Farhat, S., Jain, N., Singh, N., Sreevathsa, R., Dash, P. K., Rai, R., Yadav, S., Kumar, P., Sarkar, A. K., Jain, A., et al. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.003 · Cited by 115
Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein
Chen, R., Huang, H., Liu, H., Xi, J., Ning, J., Zeng, W., Shen, C., Zhang, T., Yu, G., Xu, Q., et al. (2019) · Small · doi:10.1002/smll.201902686 · Cited by 104
Plug-and-Play Protein Modification Using Homology-Independent Universal Genome Engineering
Gao, Y., Hisey, E., Bradshaw, T. W. A., Erata, E., Brown, W. E., Courtland, J. L., Uezu, A., Xiang, Y., Diao, Y., & Soderling, S. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.047 · Cited by 100
“CRISPR-associated endonuclease Cas9-based strategies have great promise to enable highly precise genome editing of mammalian cells to address many of the above limitations (Cong et al., 2013; Doudna and Charpentier, 2014; Hsu et al., 2014; Jinek et al., 2012; Mali et al., 2013).”
BackgroundA novel plasmid– Escherichia coli system produces large batch dsRNAs for insect gene silencing
Ma, Z., Zhou, H., Wei, Y., Yan, S., & Shen, J. (2020) · Pest Management Science · doi:10.1002/ps.5792 · Cited by 116
De Masi, C., Spitalieri, P., Murdocca, M., Novelli, G., & Sangiuolo, F. (2020) · Human Genomics · doi:10.1186/s40246-020-00276-2 · Cited by 91
“They have been engineered as a single guide RNA (sgRNA) with two critical features: a sequence at the 5′ side, that determines the DNA target site by base pairing, and a duplex RNA structure at the 3′ side that binds to Cas9 [40].”
BackgroundInfluentialMukai, H., Ogawa, K., Kato, N., & Kawakami, S. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100450 · Cited by 117
Hong, H., Han, H., Wang, L., Cao, W., Hu, M., Li, J., Wang, J., Yang, Y., Xu, X., Li, G., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-024-01436-w · Cited by 127
A glance at genome editing with CRISPR–Cas9 technology
Barman, A., Deb, B., & Chakraborty, S. (2019) · Current Genetics · doi:10.1007/s00294-019-01040-3 · Cited by 79
Advances in mRNA non-viral delivery approaches
Ibba, M. L., Ciccone, G., Esposito, C. L., Catuogno, S., & Giangrande, P. H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113930 · Cited by 112
Cell fate decisions, transcription factors and signaling during early retinal development
Diacou, R., Nandigrami, P., Fiser, A., Liu, W., Ashery‐Padan, R., & Cvekl, A. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101093 · Cited by 121
Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity
Nguyen, D. P., Miyaoka, Y., Gilbert, L. A., Mayerl, S. J., Lee, B. H., Weissman, J. S., Conklin, B. R., & Wells, J. A. (2016) · Nature Communications · doi:10.1038/ncomms12009 · Cited by 105
Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a
Creutzburg, S. C. A., Wu, W. Y., Mohanraju, P., Swartjes, T., Alkan, F., Gorodkin, J., Staals, R. H. J., & John van der, O. O. S. T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1240 · Cited by 115
“…at position 25 was designed to force a mismatch with the nucleotide at [ n –1], in an attempt not to extend the base pairing beyond 20–24; for example, the design of crRNA Back-fold lib [2] was such that positions 2–6 base paired with positions 20– RNA design was L-FR-Sp-| T | (pTarget1).”
Chiu, W., Lin, T.-Y., Chang, Y.-C., Lai, H. I. A. M., Lin, S.-C., Ma, C., Yarmishyn, A. A., Lin, S.-C., Chang, K.-J., Chou, Y.-B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094534 · Cited by 116
Susceptibility reversed: modified plant susceptibility genes for resistance to bacteria
Koseoglou, E., van der Wolf, J. M., Visser, R. G. F., & Bai, Y. (2021) · Trends in Plant Science · doi:10.1016/j.tplants.2021.07.018 · Cited by 113
Signaling cascades in the failing heart and emerging therapeutic strategies
He, X., Du, T., Long, T., Liao, X., Dong, Y., & Huang, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00972-6 · Cited by 114
“Although gene editing can be achieved by some technologies, such as zinc finger nucleases (ZFNs)(498) and transcription activator-like effector nucleases (TALENs),(499) the recent discovery of a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPRassociated 9 (Cas9) system boosted research in this…”
BackgroundSelvaraj, S., Feist, W. N., Viel, S., Vaidyanathan, S., Dudek, A. M., Gastou, M., Rockwood, S. J., Ekman, F. K., Oseghale, A., Xu, L., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01888-4 · Cited by 110
Gurr, G. M., & You, M. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2015.01255 · Cited by 118
Enabling functional genomics with genome engineering
Hilton, I. B., & Gersbach, C. A. (2015) · Genome Research · doi:10.1101/gr.190124.115 · Cited by 104
“Prokaryotes harboring type II CRISPR/Cas systems transcribe CRISPR-RNAs (crRNAs) that hybridize with trans-activating crRNAs (tracrRNAs) that complex with the Cas9 nuclease (Brouns et al. 2008; Deltcheva et al. 2011; Jinek et al. 2012; Doudna and Charpentier 2014).”
BackgroundCorrection of muscular dystrophies by CRISPR gene editing
Chemello, F., Bassel-Duby, R., & Olson, E. N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136873 · Cited by 99
“Engineered CRISPR/Cas systems In addition to the endogenous Cas proteins, engineered Cas proteins offer new genome editing tools and expand therapeutic effective method to alter the genome (12).”
BackgroundSimultaneous Targeting of Multiple Gene Homeologs to Alter Seed Oil Production in Camelina sativa
Aznar‐Moreno, J. A., & Durrett, T. P. (2017) · Plant and Cell Physiology · doi:10.1093/pcp/pcx058 · Cited by 112
Casposons: mobile genetic elements that gave rise to the CRISPR-Cas adaptation machinery
Krupovic, M., Béguin, P., & Koonin, E. V. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.04.004 · Cited by 102
“CRISPRCas systems specifically recognize and degrade, in a sequence-dependent manner, invading foreign DNA and/or RNA of viral or plasmid origin [1,2,3 ,4,5].”
BackgroundCasalino, L., Nierzwicki, Ł., Jínek, M., & Palermo, G. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c03566 · Cited by 106
Biosynthesis, bioactivity, biotoxicity and applications of antimicrobial peptides for human health
Wei, D., & Zhang, X.-W. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2022.02.003 · Cited by 116
CRISPR-based gene editing technology and its application in microbial engineering
Wei, J., & Li, Y. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100101 · Cited by 116
Gantz, V. M., & Bier, E. (2015) · BioEssays · doi:10.1002/bies.201500102 · Cited by 115
Lenka, S. K., Carbonaro, N. J., Park, R., Miller, S. M., Thorpe, I. F., & Li, Y. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.06.004 · Cited by 126
“4.2.2 Genome editing AC C EP TE D M AN U SC R IP T Genome editing is fast becoming routine in many organisms (Doudna and Charpentier, 2014, Hilton and Gersbach, 2015), but unfortunately adaptation of this methodology to microalgae has been slow.”
BackgroundInfluentialVersatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation
Braun, C. J., Bruno, P. M., Horlbeck, M. A., Gilbert, L. A., Weissman, J. S., & Hemann, M. T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600582113 · Cited by 101
“This approach has been used to elegantly study mutational phenotypes (10) and to screen for novel mediators of disease (11–15).”
MethodProndzynski, M., Krämer, E., Laufer, S. D., Shibamiya, A., Pleß, O., Flenner, F., Müller, O. J., Münch, J., Redwood, C. S., Hansen, A., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.05.008 · Cited by 108
Systems and synthetic biology for the biotechnological application of cyanobacteria
Hagemann, M., & Hess, W. R. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.07.008 · Cited by 115
McAllister, K. N., Bouillaut, L., Kahn, J. N., Self, W. T., & Sorg, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15236-5 · Cited by 110
Photoswitchable gRNAs for Spatiotemporally Controlled CRISPR-Cas-Based Genomic Regulation
Moroz, E., Satyapertiwi, D., Ramel, M., Høgset, H., Sunyovszki, I., Liu, Z., Wojciechowski, J. P., Zhang, Y., Grigsby, C. L., Brito, L., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01093 · Cited by 108
Fan, Y., Zhang, X., Zhong, L.-J., Wang, X.-Y., Jin, L., & Lyu, S.-H. (2020) · BMC Plant Biology · doi:10.1186/s12870-020-02421-4 · Cited by 104
“The soybean Rfg1 gene restricts nodulation by Sinorhizobium fredii USDA193.”
MethodInfluentialWang, Y., Shahi, P. K., Wang, X., Xie, R., Zhao, Y., Wu, M., Roge, S., Pattnaik, B. R., & Gong, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.030 · Cited by 108
Garus, A., & Autexier, C. (2021) · RNA · doi:10.1261/rna.078953.121 · Cited by 111
“While disease phenotypes caused by point mutations in DKC1 can be rescued by expression of wild-type dyskerin, a CRISPRbased approach (Doudna and Charpentier 2014) could be studied as an alternative option for treating DC. Clinical trials using CRISPR to treat genetic conditions have already been…”
Background
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.